【摘要】 目的:对某三甲医院抗肿瘤药物用药的现状和趋势做出评价。方法:对该院2000～2004年使用抗肿瘤药物进行回顾性分析。结果:抗肿瘤药销售金额逐年上升;抗肿瘤辅助治疗药格拉司琼连续5年销售金额名列第一;5年中抗雌激素类抗肿瘤药他莫昔芬用药频度排名稳居榜首,其他类抗肿瘤药顺铂位居第二;国产药物销售金额始终最大;医保类药物在该院具有较高使用率。结论:该三甲医院抗肿瘤药物结构基本合理;坚持研发和使用国产药物,不断降低药品费用。更多还原

【Abstract】 Objective: To evaluate present conditions and trend of anticancer drugs used in a 3A grade hospital. Method: Anticancer drugs used during the period 2000 - 2004 in that hospital was analysed retrospectively. Result: The sale sum of money of anticancer drugs increased year by year, in which that of Granisetron of supplementary drugs ranked in the first place for 5 years running. According to the order of DDDs, Tamoxifen of anti-female hormone stably ranked top during 5 years, and Cisplatin ranked in the second place. The sale sum of money of domestic drugs was always the highest in the 5 years. There were high proportions of medicine-insurance drugs used in the hospital. Conclusion: There was a stable and rational structure of anticancer drugs in the 3A grade hospital. Keeping using domestic drugs so as to reduce the drug costs gradually.更多还原